vs
loanDepot, Inc.（LDI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
loanDepot, Inc.的季度营收约是Orthofix Medical Inc.的1.4倍（$310.3M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -7.2%，领先6.2%），loanDepot, Inc.同比增速更快（20.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-648.0M），过去两年loanDepot, Inc.的营收复合增速更高（18.0% vs 8.0%）
loanDepot, Inc.是一家总部位于美国加利福尼亚州欧文市的非银行控股公司，主营抵押贷款及其他非抵押类贷款产品的销售业务，是美国市场上颇具规模的消费信贷服务提供商。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LDI vs OFIX — 直观对比
营收规模更大
LDI
是对方的1.4倍
$219.9M
营收增速更快
LDI
高出18.5%
2.0%
净利率更高
OFIX
高出6.2%
-7.2%
自由现金流更多
OFIX
多$664.8M
$-648.0M
两年增速更快
LDI
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $310.3M | $219.9M |
| 净利润 | $-22.5M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -10.3% | 0.2% |
| 净利率 | -7.2% | -1.0% |
| 营收同比 | 20.5% | 2.0% |
| 净利润同比 | 32.4% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LDIOFIX
| Q4 25 | $310.3M | $219.9M | ||
| Q3 25 | $323.3M | $205.6M | ||
| Q2 25 | $282.5M | $203.1M | ||
| Q1 25 | $273.6M | $193.6M | ||
| Q4 24 | $257.5M | $215.7M | ||
| Q3 24 | $314.6M | $196.6M | ||
| Q2 24 | $265.4M | $198.6M | ||
| Q1 24 | $222.8M | $188.6M |
净利润LDIOFIX
| Q4 25 | $-22.5M | $-2.2M | ||
| Q3 25 | $-4.9M | $-22.8M | ||
| Q2 25 | $-13.4M | $-14.1M | ||
| Q1 25 | $-21.9M | $-53.1M | ||
| Q4 24 | $-33.2M | $-29.1M | ||
| Q3 24 | $1.4M | $-27.4M | ||
| Q2 24 | $-32.2M | $-33.4M | ||
| Q1 24 | $-34.3M | $-36.0M |
毛利率LDIOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率LDIOFIX
| Q4 25 | -10.3% | 0.2% | ||
| Q3 25 | -3.2% | -8.3% | ||
| Q2 25 | -11.4% | -7.9% | ||
| Q1 25 | -16.8% | -25.2% | ||
| Q4 24 | -32.7% | -5.3% | ||
| Q3 24 | 1.1% | -9.6% | ||
| Q2 24 | -29.1% | -12.5% | ||
| Q1 24 | -38.2% | -15.6% |
净利率LDIOFIX
| Q4 25 | -7.2% | -1.0% | ||
| Q3 25 | -1.5% | -11.1% | ||
| Q2 25 | -4.7% | -6.9% | ||
| Q1 25 | -8.0% | -27.4% | ||
| Q4 24 | -12.9% | -13.5% | ||
| Q3 24 | 0.4% | -13.9% | ||
| Q2 24 | -12.1% | -16.8% | ||
| Q1 24 | -15.4% | -19.1% |
每股收益（稀释后）LDIOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | $0.01 | $-0.71 | ||
| Q2 24 | $-0.18 | $-0.88 | ||
| Q1 24 | $-0.19 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $337.2M | $82.0M |
| 总债务越低越好 | $2.1B | — |
| 股东权益账面价值 | $386.0M | $450.0M |
| 总资产 | $6.9B | $850.6M |
| 负债/权益比越低杠杆越低 | 5.44× | — |
8季度趋势，按日历期对齐
现金及短期投资LDIOFIX
| Q4 25 | $337.2M | $82.0M | ||
| Q3 25 | $459.2M | $62.9M | ||
| Q2 25 | $408.6M | $65.6M | ||
| Q1 25 | $371.5M | $58.0M | ||
| Q4 24 | $421.6M | $83.2M | ||
| Q3 24 | $483.0M | $30.1M | ||
| Q2 24 | $533.2M | $26.4M | ||
| Q1 24 | $603.7M | $27.0M |
总债务LDIOFIX
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $157.2M | ||
| Q2 25 | $2.1B | $157.0M | ||
| Q1 25 | $2.0B | $156.9M | ||
| Q4 24 | $2.0B | $157.0M | ||
| Q3 24 | $2.0B | $118.5M | ||
| Q2 24 | $2.0B | $118.0M | ||
| Q1 24 | $2.3B | $118.2M |
股东权益LDIOFIX
| Q4 25 | $386.0M | $450.0M | ||
| Q3 25 | $433.3M | $442.5M | ||
| Q2 25 | $439.1M | $458.3M | ||
| Q1 25 | $469.3M | $458.3M | ||
| Q4 24 | $506.6M | $503.1M | ||
| Q3 24 | $592.0M | $525.9M | ||
| Q2 24 | $578.9M | $546.0M | ||
| Q1 24 | $637.3M | $570.3M |
总资产LDIOFIX
| Q4 25 | $6.9B | $850.6M | ||
| Q3 25 | $6.2B | $832.6M | ||
| Q2 25 | $6.2B | $837.2M | ||
| Q1 25 | $6.4B | $823.1M | ||
| Q4 24 | $6.3B | $893.3M | ||
| Q3 24 | $6.4B | $867.9M | ||
| Q2 24 | $5.9B | $882.0M | ||
| Q1 24 | $6.2B | $906.0M |
负债/权益比LDIOFIX
| Q4 25 | 5.44× | — | ||
| Q3 25 | 4.83× | 0.36× | ||
| Q2 25 | 4.70× | 0.34× | ||
| Q1 25 | 4.30× | 0.34× | ||
| Q4 24 | 4.00× | 0.31× | ||
| Q3 24 | 3.31× | 0.23× | ||
| Q2 24 | 3.41× | 0.22× | ||
| Q1 24 | 3.63× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-638.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-648.0M | $16.8M |
| 自由现金流率自由现金流/营收 | -208.9% | 7.6% |
| 资本支出强度资本支出/营收 | 3.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-734.6M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LDIOFIX
| Q4 25 | $-638.7M | $27.7M | ||
| Q3 25 | $43.4M | $12.4M | ||
| Q2 25 | $67.6M | $11.6M | ||
| Q1 25 | $-179.9M | $-18.4M | ||
| Q4 24 | $47.7M | $23.7M | ||
| Q3 24 | $-349.2M | $11.7M | ||
| Q2 24 | $-278.3M | $9.0M | ||
| Q1 24 | $-278.5M | $-18.6M |
自由现金流LDIOFIX
| Q4 25 | $-648.0M | $16.8M | ||
| Q3 25 | $38.7M | $2.5M | ||
| Q2 25 | $61.4M | $4.5M | ||
| Q1 25 | $-186.7M | $-25.1M | ||
| Q4 24 | $40.8M | $15.2M | ||
| Q3 24 | $-356.4M | $6.3M | ||
| Q2 24 | $-285.7M | $-360.0K | ||
| Q1 24 | $-283.3M | $-29.1M |
自由现金流率LDIOFIX
| Q4 25 | -208.9% | 7.6% | ||
| Q3 25 | 12.0% | 1.2% | ||
| Q2 25 | 21.7% | 2.2% | ||
| Q1 25 | -68.2% | -13.0% | ||
| Q4 24 | 15.8% | 7.0% | ||
| Q3 24 | -113.3% | 3.2% | ||
| Q2 24 | -107.7% | -0.2% | ||
| Q1 24 | -127.2% | -15.4% |
资本支出强度LDIOFIX
| Q4 25 | 3.0% | 4.9% | ||
| Q3 25 | 1.5% | 4.8% | ||
| Q2 25 | 2.2% | 3.5% | ||
| Q1 25 | 2.5% | 3.5% | ||
| Q4 24 | 2.7% | 4.0% | ||
| Q3 24 | 2.3% | 2.7% | ||
| Q2 24 | 2.8% | 4.7% | ||
| Q1 24 | 2.1% | 5.6% |
现金转化率LDIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -255.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LDI
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
